{"id":239844,"date":"2021-08-09T10:18:45","date_gmt":"2021-08-09T10:18:45","guid":{"rendered":"https:\/\/scienze.fanpage.it\/?p=217650"},"modified":"2021-08-09T10:18:45","modified_gmt":"2021-08-09T10:18:45","slug":"nuovo-farmaco-covid-da-risultati-promettenti-il-93-dei-pazienti-dimesso-in-5-giorni","status":"publish","type":"post","link":"https:\/\/nugnes.com\/?p=239844","title":{"rendered":"Nuovo farmaco Covid d\u00e0 risultati promettenti: \u201cIl 93% dei pazienti dimesso in 5 giorni\u201d"},"content":{"rendered":"<img src=\"https:\/\/static.fanpage.it\/wp-content\/uploads\/sites\/5\/2021\/08\/GettyImages-1210482415-300x225.jpg\" \/><br \/>Chiamato EXO-CD4, il trattamento sperimentale \u00e8 stato sviluppato dal team israeliano del Sourasky Medical Center di Tel Aviv e testato in uno studio di fase II condotto in diversi ospedali in Grecia: \u201cAbbiamo trovato lo strumento per affrontare la malattia\u201d.<br \/><a href=\"https:\/\/scienze.fanpage.it\/nuovo-farmaco-covid-da-risultati-promettenti-il-93-dei-pazienti-dimesso-in-5-giorni\/\">Continua a leggere<\/a>","protected":false},"excerpt":{"rendered":"<p>Chiamato EXO-CD4, il trattamento sperimentale \u00e8 stato sviluppato dal team israeliano del Sourasky Medical Center di Tel Aviv e testato in uno studio di fase II condotto in diversi ospedali in Grecia: \u201cAbbiamo trovato lo strumento per affrontare la mala&#8230;<\/p>\n","protected":false},"author":143,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-239844","post","type-post","status-publish","format-standard","hentry","category-salute"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/239844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/users\/143"}],"replies":[{"embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=239844"}],"version-history":[{"count":1,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/239844\/revisions"}],"predecessor-version":[{"id":239845,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/239844\/revisions\/239845"}],"wp:attachment":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=239844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=239844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=239844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}